Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

You are here: Home » Trials & Approvals

Trials & Approvals


Updates on new clinical tirals being performed in China, trial updates and drug approvals...

Recent Articles

  Sensus Gains China Approval of Radiation Device for Keloids
  DelMar Approved to Start China Phase II Trial of Brain Cancer Treatment
  Lee's Pharm and SillaJen Approved for China Immunotherapy Trial
  Ascentage Approved to Start China Trial of Apoptosis Drug
  CStone Approved to Start China Trials of PD-L1 Candidate
  Resverlogix and Hepalink Start Taiwan/China Trial of CVD/Diabetes Treatment
  BeyondSpring Granted Approval to Start China Trials of Plinabulin
  CFDA Accepts Athenex's IND Filing for Oral Paclitaxel
  BeiGene Starts Second China Pivotal Phase II Trial of PD-1 Drug
  Chi-Med/AstraZeneca Partnership Starts Phase III Trial of c-MET Inhibitor